Back to results

CompletedPhase 4

The Clinical Response of Choline Acetyltransferase and Apolipoprotein Epsilon Gene Polymorphisms to Donepezil in Alzheimer's Disease

NCT00381381

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Seoul National University Bundang Hospital

Bundang, South Korea

+14 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2006-05-31
Enrollment: 199 participants
Sponsor: Eisai Korea Inc.
Purpose: treatment

Locations (15)

Seoul National University Bundang HospitalBundang, South Korea
Hallym University Medical CenterChangwon, South Korea
Kangwon National University HospitalChuncheon, South Korea
Kunkuk University Chungju HospitalChungju, South Korea
Kyungpook National University HospitalDaegu, South Korea
Chungnam National University HospitalDaejeon, South Korea
Gyeonggi Province Geriatric HospitalGyeonggi-do, South Korea
Uijeongbu St. Mary's HospitalGyeonggi-do, South Korea
Jeju National University HospitalJeju City, South Korea
Jeonju City Welfare HospitalJeonju, South Korea
Gyeongsang National University HospitalJinju, South Korea
Inje University Pusan Paik HospitalPusan, South Korea
Kunkuk University HospitalSeoul, South Korea
Seoul National University HospitalSeoul, South Korea
Seoul St. Mary's HospitalSeoul, South Korea

The Clinical Response of Choline Acetyltransferase and Apolipoprotein Epsilon Gene Polymorphisms to Donepezil in Alzheimer's Disease — TrialFind